Skip to content

Q and A with Irving Weissman

Q and A final copy.jpg

Stanford stem cell researcher Irving Weissman, MD, recently assumed the presidency of the International Society for Stem Cell Research. Writing for Nature Reports Stem Cells, Monya Baker seized the opportunity to talk with him about his plans for the organization and his feelings about the recent human embryonic stem cell research guidelines set by the National Institutes of Health.

Weissman's dissatisfaction with the guidelines has been made clear in several different forums. (You can view a podcast of a conversation between Weissman and my boss and fellow blogger Paul Costello here, or read a release detailing his thoughts here.) One thing I haven't heard him talk much about before, though, is a proposal to rein in some of the more outrageous stem-cell therapy claims by calling them out as 'unproven'. It's long overdue, in my opinion. Too many desperate people around the world are clutching at therapeutic straws dangled by unethical psuedo-scientists. Even if we can't yet give them a cure, these patients deserve reasoned guidance from professionals motivated by ethics rather than money.

Via Nature Reports Stem Cells

Letters Q and A brought to you today by Eva the Weaver
Ampersand by Leo Reynolds

Popular posts

Category:
Biomedical research
Stanford immunologist pushes field to shift its research focus from mice to humans

Much of what we know about the immune system comes from experiments conducted on mice.  But lab mice are not little human beings. The two species are separated by both physiology and  lifestyles. Stanford immunologist Mark Davis is calling on his colleagues to shift their research focus to people.